Clinical Trials Browser

Phase 1/2 × Sarcoma × N-dihydrogalactochitosan × Clear all

NCT03993678 2025-12-30

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Phase 1/2 Completed

DermatologicSarcoma

Melanoma, Sarcoma